Aberdeen Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
WHG
Aberdeen Group's CNMD Position: Q2 2025 in Review
Aberdeen Group sold out of CONMED (CNMD) in Q2 2025, closing a stake of 141,186 shares — an estimated $8.53M sold.
Aberdeen Group first reported a position in CNMD in Q2 2021 and held it in 16 quarters. The position peaked at $48.8M in Q4 2021. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.
- Aberdeen Group reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
- Aberdeen Group sold 141,186 CONMED shares in Q2 2025, an estimated $8.53M.
- Aberdeen Group first reported a position in CONMED in Q2 2021 and held it in 16 quarters.
- Aberdeen Group's CONMED position peaked at $48.8M in Q4 2021.
- 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.
Based on Aberdeen Group's 13F filing for Q2 2025, filed 24 Jul 2025.